- Home
- MESA vs LVTX Comparison
MESA vs LVTX Comparison
Compare MESA & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- LVTX
- Stock Information
- Founded
- MESA 1982
- LVTX 2016
- Country
- MESA United States
- LVTX Netherlands
- Employees
- MESA N/A
- LVTX N/A
- Industry
- MESA Air Freight/Delivery Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- LVTX Health Care
- Exchange
- MESA Nasdaq
- LVTX Nasdaq
- Market Cap
- MESA 42.2M
- LVTX 33.9M
- IPO Year
- MESA 2018
- LVTX 2021
- Fundamental
- Price
- MESA $1.18
- LVTX $1.43
- Analyst Decision
- MESA
- LVTX Hold
- Analyst Count
- MESA 0
- LVTX 3
- Target Price
- MESA N/A
- LVTX $1.75
- AVG Volume (30 Days)
- MESA 129.7K
- LVTX 20.5K
- Earning Date
- MESA 08-15-2025
- LVTX 08-19-2025
- Dividend Yield
- MESA N/A
- LVTX N/A
- EPS Growth
- MESA N/A
- LVTX N/A
- EPS
- MESA N/A
- LVTX N/A
- Revenue
- MESA $424,030,000.00
- LVTX $4,990,000.00
- Revenue This Year
- MESA $39.81
- LVTX N/A
- Revenue Next Year
- MESA N/A
- LVTX N/A
- P/E Ratio
- MESA N/A
- LVTX N/A
- Revenue Growth
- MESA N/A
- LVTX N/A
- 52 Week Low
- MESA $0.68
- LVTX $0.85
- 52 Week High
- MESA $1.87
- LVTX $2.32
- Technical
- Relative Strength Index (RSI)
- MESA 75.86
- LVTX 63.92
- Support Level
- MESA $0.91
- LVTX $1.27
- Resistance Level
- MESA $1.07
- LVTX $1.45
- Average True Range (ATR)
- MESA 0.04
- LVTX 0.05
- MACD
- MESA 0.02
- LVTX 0.01
- Stochastic Oscillator
- MESA 94.44
- LVTX 79.40
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.